Minimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira).

about

Dipeptidyl peptidase-4 inhibitors or sodium glucose co-transporter-2 inhibitors as an add-on to insulin therapy: A comparative review Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin: rationale and evidences.

P2860

Q26767260-E5331EEE-E1BD-40F1-96C5-3537C48BE81B Q38687258-CEA26787-BEFD-47B2-904D-AD5F86E39059

P2860

Minimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira).

Item

http://www.wikidata.org/entity/Q35666228

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Minimizing Hypoglycemia and We ...... ombination Therapy (IDegLira).

@ast

Minimizing Hypoglycemia and We ...... ombination Therapy (IDegLira).

@en

type

Item

label

Minimizing Hypoglycemia and We ...... ombination Therapy (IDegLira).

@ast

Minimizing Hypoglycemia and We ...... ombination Therapy (IDegLira).

@en

prefLabel

Minimizing Hypoglycemia and We ...... ombination Therapy (IDegLira).

@ast

Minimizing Hypoglycemia and We ...... ombination Therapy (IDegLira).

@en

P1476

Minimizing Hypoglycemia and We ...... ombination Therapy (IDegLira).

@en

P2093

Javier Morales

http://www.w3.org/2001/XMLSchema#string

Ludwig Merker

http://www.w3.org/2001/XMLSchema#string

P2860

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

Glucose control and vascular complications in veterans with type 2 diabetes

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

The once-daily human glucagon-like peptide-1 analog, liraglutide, improves β-cell function in Japanese patients with type 2 diabetes.

Barriers to insulin initiation: the translating research into action for diabetes insulin starts project.

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.

P2888

s12325-015-0208-2

P304

391-403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12325-015-0208-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276210200

http://www.w3.org/2001/XMLSchema#string

P698

25962992

http://www.w3.org/2001/XMLSchema#string

P921

hypoglycemia

weight gain

P932

4449377

http://www.w3.org/2001/XMLSchema#string

Minimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira).

about

P2860

P2860

Minimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932